Reporting owner · CIK 0001721442

Sabag Mark

SEC Form 4 history for the last 180 days across 1 company, 6 transactions and 2 filings.

SRSee "Remarks"TEVA PHARMACEUTICAL INDUSTRIES LTD
Open-market transaction mix0% buys0 buys · 2 sales

Period: Last 180 days

Trade dates in this period: Nov 5, 2026 – Nov 12, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings2Form 4 records
Buying$00 purchases
Selling$3.90M2 sales
Net value−$3.90MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
Sabag Mark transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
SR
SR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
SR
SR
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$1.97MView disclosure →
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
SR
SR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
$1.56MView disclosure →
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
SR
SR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
SR
SR
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$1.93MView disclosure →
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
SR
SR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
$1.61MView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

The insider reported a sale at TEVA PHARMACEUTICAL INDUSTRIES LTD on Nov 12, 2026 valued at $1,973,544.11.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Monthly open-market activity

Last 1 reported month · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Nov 202602$0$3,902,273.51−$3,902,273.51

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$1.95M
Median P/S size$1.95M
Direct6
Indirect0
Nov 12, 2026exercise

Associated companies

Counts cover all available history, including outside the summary period

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in the last 180 days

A 90-day purchase return requires an open-market buy. None is recorded in the last 180 days. Purchases filed earlier are outside the visible history and are not included.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

4 observations · Nov 5, 2026 – Nov 12, 2026. Window ends at the latest available report, not today.

Selected observation · Nov 12, 202680,760 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Nov 5, 2026126,760Nov 6, 2026View transaction
Nov 5, 202680,760Nov 6, 2026View transaction
Nov 12, 2026125,470Nov 12, 2026View transaction
Nov 12, 202680,760Nov 12, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Sabag Mark Insider Activity FAQ

SEC Form 4 context

Who is Sabag Mark?

Sabag Mark is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001721442.

Which companies has Sabag Mark reported transactions for?

TEVA PHARMACEUTICAL INDUSTRIES LTD

When was Sabag Mark's latest insider buy?

No open-market insider purchase is recorded in the last 180 days. Earlier filings are outside the visible history.

When was Sabag Mark's latest insider sale?

The insider reported a sale at TEVA PHARMACEUTICAL INDUSTRIES LTD on Nov 12, 2026 valued at $1,973,544.11.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.